Literature DB >> 28417877

Tobacco and diabetes: clinical relevance and approach to smoking cessation in diabetic smokers.

Marco López Zubizarreta1, Miguel Ángel Hernández Mezquita2, José Manuel Miralles García3, Miguel Barrueco Ferrero4.   

Abstract

Smoking is, together with diabetes mellitus, one of the main risk factors for cardiovascular disease. Diabetic patients have unique features and characteristics, some of which are not well known, that cause smoking to aggravate the effects of diabetes and impose difficulties in the smoking cessation process, for which a specificand more intensive approach with stricter controls is required. This review details all aspects with a known influence on the interaction between smoking and diabetes, both as regards the increased risk of macrovascular and microvascular complications of diabetes and the factors with an impact on the results of smoking cessation programs. The treatment guidelines for these smokers, including the algorithms and drug treatment patterns which have proved most useful based on scientific evidence, are also discussed.
Copyright © 2017 SEEN. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Bupropion; Bupropión; Diabetes mellitus; Nicotine Replacement Therapy; Smoking; Tabaquismo; Terapia Sustitutiva de Nicotina; Vareniclina; Varenicline

Mesh:

Substances:

Year:  2017        PMID: 28417877     DOI: 10.1016/j.endinu.2017.02.010

Source DB:  PubMed          Journal:  Endocrinol Diabetes Nutr        ISSN: 2530-0164


  4 in total

1.  Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial.

Authors:  J I Aguayo-Ruiz; T A García-Cobián; S Pascoe-González; S Sánchez-Enríquez; I M Llamas-Covarrubias; T García-Iglesias; A López-Quintero; M A Llamas-Covarrubias; J Trujillo-Quiroz; E A Rivera-Leon
Journal:  Diabetol Metab Syndr       Date:  2020-08-18       Impact factor: 3.320

2.  Smoke exposure and cardio-metabolic profile in youth with type 1 diabetes.

Authors:  Valeria Calcaterra; Jonathan P Winickoff; Catherine Klersy; Luca Maria Schiano; Rossella Bazzano; Chiara Montalbano; Valeria Musella; Corrado Regalbuto; Daniela Larizza; Hellas Cena
Journal:  Diabetol Metab Syndr       Date:  2018-07-06       Impact factor: 3.320

3.  Changes in secondhand smoke exposure levels and risk of type 2 diabetes in middle age: the Korean Genome and Epidemiology Study (KoGES).

Authors:  Jooeun Jeon; Keum Ji Jung; Heejin Kimm; Sun Ha Jee
Journal:  BMJ Open Diabetes Res Care       Date:  2019-12-08

4.  Insulin restores the neurochemical effects of nicotine in the mesolimbic pathway of diabetic rats.

Authors:  Bryan Cruz; Luis M Carcoba; Rodolfo J Flores; Evangelina J Espinoza; Arbi Nazarian; Laura E O'Dell
Journal:  J Neurochem       Date:  2020-07-22       Impact factor: 5.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.